ChemInform Abstract: Improved Syntheses of Epristeride, a Potent Human 5α-Reductase Inhibitor.
✍ Scribed by N. H. BAINE; F. F. OWINGS; D. N. KLINE; T. RESNICK; L.-J. PING; M. FOX; R. E. MEWSHAW; A. M. TICKNER; C. J. KOWALSKI
- Book ID
- 112021655
- Publisher
- John Wiley and Sons
- Year
- 2010
- Weight
- 33 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0931-7597
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
BACKGROUND. Inhibitors of 5␣ reductase (5␣R), the enzyme that converts testosterone to dihydrotestosterone (DHT), have been shown to retard the growth of hyperplastic prostates. This study evaluates the effects of the 5␣R inhibitor, epristeride, on cultured stromal and epithelial cells from benign,
a b s t r a c t Finasteride and epristeride both inhibit 5a-reductase with high potency via competitive and non-competitive mechanism, respectively. A new hybrid of finasteride and epristeride was designed as a new 5a-reductase inhibitor based on combination principles in medicinal chemistry. Human